Externally anchored fully covered metal stents with plastic stent versus uncovered metal stents for unresectable distal malignant biliary obstruction: a multicenter randomized trial

Abstract Self-expandable metal stents (SEMS) are commonly used to treat malignant biliary obstruction (MBO). External plastic stent anchoring for fully covered SEMS (FCSEMS-EPS) has shown potential to improve stent patency; however, randomized evidence comparing this strategy with uncovered SEMS (USEMS) is limited. This multicenter trial was conducted at nine tertiary referral centers in South Korea. Patients were enrolled from October 2021 to February 2024 and followed for 12 months after stent placement. Those with unresectable distal MBO were randomly assigned (1:1) to receive either FCSEMS-EPS or USEMS. The primary outcome was biliary stent dysfunction. Time-to-event analyses were performed using time to stent dysfunction within a competing risk framework. 113 patients were enrolled, of whom 99 were included in the final analysis (FCSEMS-EPS 48; USEMS 51). Stent dysfunction occurred less frequently in the FCSEMS-EPS group compared with the USEMS group (27.1% vs. 49.0%; P = 0.04). The cumulative incidence of stent dysfunction at 6 months was lower in the FCSEMS-EPS group (21.1% vs. 29.8%; Gray’s test, P = 0.03). In multivariable competing risk analysis, FCSEMS-EPS was independently associated with a lower risk of stent dysfunction (subdistribution hazard ratio 0.44, 95%CI 0.21–0.90; P = 0.03). Procedure-related adverse events and overall survival did not differ between groups. FCSEMS-EPS significantly reduced stent dysfunction compared with USEMS without increasing adverse events, supporting its effectiveness and safety as long-term biliary drainage in unresectable MBO.

Authors

Institutions

Publication Details

Journal
Endoscopy
Published
2026-11-16
DOI
https://doi.org/10.1055/a-2963-1915
Primary Topic
Gallbladder and Bile Duct Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Externally anchored fully covered metal stents with plastic stent versus uncovered metal stents for unresectable distal malignant biliary obstruction: a multicenter randomized trial

Joo Seong Kim, Woo Sang Myung, Sang Hyub Lee, Min Kyu Jung et al.
3 links
Endoscopy
Gallbladder and Bile Duct Disorders
article

Externally anchored fully covered metal stents with plastic stent versus uncovered metal stents for unresectable distal malignant biliary obstruction: a multicenter randomized trial

Joo Seong Kim, Woo Sang Myung, Sang Hyub Lee, Min Kyu Jung, Eunae Cho, Junyeol Kim, Dong‐Won Ahn, Seong-Hun Kim, Joung-Ho Han, I R Cho, Ji Kon Ryu, Jin Ho Choi, Eaum Seok Lee, Sung Yong Han, Woo Hyun Paik
article en

Abstract

Abstract Self-expandable metal stents (SEMS) are commonly used to treat malignant biliary obstruction (MBO). External plastic stent anchoring for fully covered SEMS (FCSEMS-EPS) has shown potential to improve stent patency; however, randomized evidence comparing this strategy with uncovered SEMS (USEMS) is limited. This multicenter trial was conducted at nine tertiary referral centers in South Korea. Patients were enrolled from October 2021 to February 2024 and followed for 12 months after stent placement. Those with unresectable distal MBO were randomly assigned (1:1) to receive either FCSEMS-EPS or USEMS. The primary outcome was biliary stent dysfunction. Time-to-event analyses were performed using time to stent dysfunction within a competing risk framework. 113 patients were enrolled, of whom 99 were included in the final analysis (FCSEMS-EPS 48; USEMS 51). Stent dysfunction occurred less frequently in the FCSEMS-EPS group compared with the USEMS group (27.1% vs. 49.0%; P = 0.04). The cumulative incidence of stent dysfunction at 6 months was lower in the FCSEMS-EPS group (21.1% vs. 29.8%; Gray’s test, P = 0.03). In multivariable competing risk analysis, FCSEMS-EPS was independently associated with a lower risk of stent dysfunction (subdistribution hazard ratio 0.44, 95%CI 0.21–0.90; P = 0.03). Procedure-related adverse events and overall survival did not differ between groups. FCSEMS-EPS significantly reduced stent dysfunction compared with USEMS without increasing adverse events, supporting its effectiveness and safety as long-term biliary drainage in unresectable MBO.

Endoscopy
Chonnam National University (KR), Seoul National University (KR), Chungbuk National University (KR), Seoul Metropolitan Government (KR), Seoul National University Hospital (KR), Kyungpook National University (KR), Chonnam National University Hospital (KR), SNUH SMG-SNU Boramae Medical Center (KR), Pusan National University Hospital (KR), National Cancer Center (KR), Chungnam National University Hospital (KR), Chung-Ang University (KR), Jeonbuk National University (KR)
Daewoong Pharmaceutical Company
Good health and well-being
Gallbladder and Bile Duct Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon